Corteva (CTVA) BMO Ag-Apalooza Conference summary
Event summary combining transcript, slides, and related documents.
BMO Ag-Apalooza Conference summary
20 Jan, 2026Financial and operational performance
First half of 2024 delivered solid financials, just below record 2023 levels, driven by strong seed business growth and margin expansion.
Crop protection business faced industry-wide headwinds but saw volume growth in Q2, signaling a potential turnaround.
Operational execution remains strong, with $400–$450 million in cost productivity and self-help initiatives on track for 2024.
SG&A expenses have remained flat despite acquisitions, reflecting disciplined cost management.
Over 100 new crop protection products and 250 new seed hybrids/varieties launched in H1, strengthening the technology pipeline.
Market dynamics and guidance
Full-year guidance was adjusted downward due to weather-related issues and Argentina's corn stunt, impacting Q3 and full-year seed sales.
Argentina's corn stunt is expected to reduce planted area by about 20% in 2024, with a strong Q4 anticipated for crop protection volumes.
Top end of the $3.4–$3.6 billion full-year guide is now unlikely, but the company remains comfortable within the range.
Brazil's safrinha corn acreage remains uncertain due to dry weather, with clarity expected in October–November.
Forward outlook and strategic initiatives
2025 guidance will be provided at Q3 results, earlier than usual, to align with Investor Day in November.
Continued seed performance and growth expected, with crop protection industry stabilization needed for further gains.
Deflationary tailwinds from lower commodity prices are anticipated to benefit COGS from 2025 through 2027.
Growth opportunities include biologicals (double-digit growth), new product launches, and out-licensing of seed traits.
Out-licensing of next-gen seed technologies (PowerCore, Vorceed) and expansion in Brazil are key value drivers.
Latest events from Corteva
- Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.CTVA
Proxy filing19 Mar 2026 - 2025 results delivered margin growth, strong governance, and pay aligned to performance and ESG.CTVA
Proxy filing19 Mar 2026 - Strong 2025 results and resilient nitrogen markets drive growth amid global and policy shifts.CTVA
Bank of America 2026 Global Agriculture and Materials Conference25 Feb 2026 - 2025 saw record margins, cash flow, and Bayer deal; 2026 set for further growth and separation.CTVA
Q4 20254 Feb 2026 - Seed strength and margin gains offset Crop Protection headwinds; 2024 outlook trimmed.CTVA
Q2 20242 Feb 2026 - 2024 guidance reaffirmed as cost savings, innovation, and strong seed performance drive long-term growth.CTVA
Wells Fargo 2024 Industrials Conference1 Feb 2026 - 2024 guidance narrowed as Q3 sales fell, but 2025 outlook targets strong EBITDA growth.CTVA
Q3 202415 Jan 2026 - Record 2024 margins and cash flow; 2025 targets 10% EBITDA growth and $1B buybacks.CTVA
Q4 20248 Jan 2026 - Q1 2025 operating EBITDA up 15% to $1.19B with margin gains; $1B buyback planned.CTVA
Q1 20258 Jan 2026